Literature DB >> 2301561

Copper transport from ceruloplasmin: characterization of the cellular uptake mechanism.

S S Percival1, E D Harris.   

Abstract

Copper uptake from 67Cu-labeled ceruloplasmin (67CuCp) was studied in K-562 cells, a human erythroleukemic cell line. 67CuCp was prepared by an ascorbate-catalyzed exchange of recrystallized ceruloplasmin with 67CuCl2. The labeled protein was treated with Chelex-100 and gel filtration to ensure that 67Cu was tightly bound to the structure. 67CuCp bound specifically to the K-562 cells at 4 degrees C. The binding was linear with protein in the range of 200-800 nM and in the presence of 3% albumin. In this concentration range, 67CuCl2 showed no binding that could be interpreted as specific; 80-90% of the cell-bound 67Cu was removed by washing the cells with acid buffer. When binding was attempted at 37 degrees C, a significant fraction of the 67Cu resisted acid washing and with time accumulated in the cells. Fractionating the cytosolic components on Percoll gradients located the 67Cu in buoyant fractions of densities 1.030-1.05, with a peak at 1.035. Repeating the experiment with 125I-labeled ceruloplasmin failed to localize any 125I label in Percoll fractions; very little 125I was detected in the cytosol. Double-labeled 67Cu-125I-ceruloplasmin confirmed that copper and not the protein moiety of ceruloplasmin was taken up by the cells. The uptake reaction was inhibited by 1 mM bathocuproine sulfonate and by 1 mM sodium iproniazid. Ascorbate (100 microM) strongly stimulated uptake. These studies provide evidence that K-562 cells are able to extract copper atoms from ceruloplasmin and transport the copper to the cytosol.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301561     DOI: 10.1152/ajpcell.1990.258.1.C140

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

Review 2.  Copper and liver disease.

Authors:  D M Danks
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

3.  Regulation of Cu,Zn superoxide dismutase with copper. Caeruloplasmin maintains levels of functional enzyme activity during differentiation of K562 cells.

Authors:  S S Percival; E D Harris
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

4.  Divalent cation binding to ceruloplasmin.

Authors:  G Musci; M C Bonaccorsi di Patti; R Petruzzelli; A Giartosio; L Calabrese
Journal:  Biometals       Date:  1996-01       Impact factor: 2.949

5.  Ceruloplasmin as a source of Cu for a fungal pathogen.

Authors:  Angelique N Besold; Vinit Shanbhag; Michael J Petris; Valeria C Culotta
Journal:  J Inorg Biochem       Date:  2021-03-15       Impact factor: 4.336

6.  Mechanism of Copper Uptake from Blood Plasma Ceruloplasmin by Mammalian Cells.

Authors:  Danny Ramos; David Mar; Michael Ishida; Rebecca Vargas; Michaella Gaite; Aaron Montgomery; Maria C Linder
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

7.  Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis.

Authors:  Yun Liao; Junjie Zhao; Katarzyna Bulek; Fangqiang Tang; Xing Chen; Gang Cai; Shang Jia; Paul L Fox; Emina Huang; Theresa T Pizarro; Matthew F Kalady; Mark W Jackson; Shideng Bao; Ganes C Sen; George R Stark; Christopher J Chang; Xiaoxia Li
Journal:  Nat Commun       Date:  2020-02-14       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.